Patents by Inventor Matthaios VIDALIS

Matthaios VIDALIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTRAVAGINAL FORMULATION
    Publication number: 20240091152
    Abstract: An intravaginal formulation comprising a dry powder composition and propellant(s) and the apparatus capable of delivery intravaginally a dry powder composition.
    Type: Application
    Filed: November 27, 2023
    Publication date: March 21, 2024
    Inventor: Matthaios VIDALIS
  • LIQUID APIXABAN FORMULATION IN SMALL DOSE VOLUME
    Publication number: 20240041856
    Abstract: A pharmaceutical liquid formulation for oral delivery of apixaban comprising i) apixaban in high concentrations, ii) more than 35% (w/v) propylene glycol based on the total formulation and ii) optionally other pharmaceutical acceptable excipients, wherein the formulation is suitable for small dose volume administration. The invention relates to a liquid formulation, which can be useful as pharmaceutical formulations, for oral delivery of apixaban with a small dose volume.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 8, 2024
    Inventor: Matthaios VIDALIS
  • Intravaginal formulation
    Patent number: 11850304
    Abstract: An intravaginal formulation comprising a dry powder composition and propellant(s) and the apparatus capable of delivery intravaginally a dry powder composition.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: December 26, 2023
    Assignee: THE MATERIA COMPANY LIMITED
    Inventor: Matthaios Vidalis
  • TOPICAL SOLUTION OF EFINACONAZOLE WITH HIGH SUBUNGUAL PENETRATION
    Publication number: 20230233462
    Abstract: A new topical solution with high subungual penetration for the treatment of a fungal infection comprising efinaconazole, a volatile polar organic solvent, at least one phenolic antioxidant and at least one phospholipid.
    Type: Application
    Filed: June 3, 2021
    Publication date: July 27, 2023
    Inventor: Matthaios VIDALIS
  • STABLE FORMULATION OF EFINACONAZOLE
    Publication number: 20230226033
    Abstract: A new stable formulation comprising efinaconazole and its process for preparing. The formulation of the present invention exhibits low levels of impurities.
    Type: Application
    Filed: June 3, 2021
    Publication date: July 20, 2023
    Inventor: Matthaios VIDALIS
  • INTRAVAGINAL FORMULATION
    Publication number: 20210030674
    Abstract: An intravaginal formulation comprising a dry powder composition and propellant(s) and the apparatus capable of delivery intravaginally a dry powder composition.
    Type: Application
    Filed: March 28, 2019
    Publication date: February 4, 2021
    Applicant: The Materia Company Limited
    Inventor: Matthaios VIDALIS